CA
NZ
UK
AU
IND
US
For the first nine months, adjusted EBITDA was USD 66.5 million, up 16% from USD 57.2 million, and revenue was USD 236.3 million compared with USD 249.2 million, a decline of approximately 5%.
Pretax loss was USD 13.4 million, compared with USD 32.1 million. Adjusted EBITDA was USD 7.1 million, compared with USD 1.1 million.
Diagnostics product sales increased 16% to USD 16.8 million from USD 14.5 million. Sample Management Solutions revenues increased 21% to USD 12.5 million from USD 10.3 million. Non-product and services revenues decreased 53% to USD 0.8 million from USD 1.7 million, primarily due to …
Net income was USD 1,821 million, compared with USD 842 million.Net Incomeattributable to common stockholders was USD 1,637 million, compared with USD 661 million, after USD 15 million attributable to noncontrolling interest and USD 169 million of preferred stock dividends.
The company's chief financial officer said revenue,Operating Marginand net income each finished above the high end of the company's third quarter guidance. Chief executive Mark Newcomer tied the results to growth in the patient affordability business.
Revenue has grown each quarter this year, from USD 163.5 million in the first quarter to USD 178.3 million in the second and approximately USD 201 million in the third. Through nine months, revenue was USD 542 million, up about 12%.
Co-Founder and Chief Executive Officer Rajeev Goel said CTV, mobile app and emerging revenues, including Activate, AI and commerce related solutions, represented nearly two thirds of revenue, up from approximately 60% a quarter earlier.
The company's chief financial officer said channel partners made up 55% of revenue, compared with 50% a year earlier. Channel revenue grew 24%, while direct revenue declined 2%. Revenue outside the United States grew 15% and domestic revenue grew 7%, giving a 54% and …
On a pro forma basis, excluding USD 2.4 million of third quarter 2025 revenue from a terminated diagnostic development program and including USD 0.6 million of Akoya pre-acquisition revenue, the year-over-year decline was 8.6%. The company's chief financial officer said the result does not …
Third quarter revenue compared with USD 384 thousand in the same period last year and exceeded the USD 9.2 million of revenue generated during the entire first half of 2026.
Please wait processing your request...